(Q40581790)

English

Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo

scientific article published on March 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

membrane fusion involved in viral entry into host cell

0 references

1 reference

based on heuristic

inferred from title

David T. Curiel

6

object named as

David T Curiel

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Angel A Rivera

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Minghui Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Kaori Suzuki

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Taco G Uil

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Victor Krasnykh

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dirk M Nettelbeck

7

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

320

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

121-134

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Replicating viruses as selective cancer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Efficient ablation by immunotoxin-mediated cell targeting of the cell types that express human interleukin-2 receptor depending on the internal ribosome entry site

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Replicating adenoviral vector-mediated transfer of a heat-inducible double suicide gene for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Internal ribosome entry site biology and its use in expression vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Intravascular adenoviral agents in cancer patients: lessons from clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Cytolytic viruses as potential anti-cancer agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

In Vivo Noninvasive Imaging for Gene Therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Development and application of adenoviral vectors for gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

Organization of the transcriptional control region of the E1b gene of adenovirus type 5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.11.028

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2003.11.028

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40581790&oldid=1903236898"